Biome Australia Ltd (AU:BIO) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Biome Australia Ltd anticipates achieving a new quarterly sales record, with Q2 FY25 revenue expected to exceed $4.5 million, surpassing its previous record of $4.25 million. This strong performance highlights Biome’s continued growth in the microbiome health sector, leveraging innovative probiotic and complementary medicines.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.